Tuberculosis News and Research

Latest Tuberculosis News and Research

TSRI scientists discover first-in-class compounds that target persistent tuberculosis

Tuberculosis has been infecting humans for several millennia, making it one of the most horribly successful diseases in history. Today, it is still a major killer, responsible for some 1.5 million deaths each year.

18 Nov 2015

Study shows how parasitic worm infection increases susceptibility to TB

Scientists have shown how a parasitic worm infection common in the developing world increases susceptibility to tuberculosis. The study demonstrated that treating the parasite reduces lung damage seen in mice that also are infected with tuberculosis, thereby eliminating the vulnerability to tuberculosis (TB) that the parasite is known to cause.

17 Nov 2015

Analyzing potential TB vaccine

When results from a landmark tuberculosis vaccine trial in Cape Town, South Africa were published in The Lancet in February 2013, the headlines were grim, despite hopes that the trial would point toward a successful way to thwart one of the globe's biggest public health threats.

13 Nov 2015

ACR releases 2015 Guideline for Treatment of Rheumatoid Arthritis

The American College of Rheumatology (ACR) released its 2015 Guideline for the Treatment of Rheumatoid Arthritis (RA) during the 2015 ACR/ARHP Annual Meeting in San Francisco.

11 Nov 2015

New funding for Centenary's life saving research

The Centenary Institute has welcomed the Federal Government’s announcement of funding for 9 new and innovative medical research projects via the latest round of NHMRC grant rounds funding, officially confirmed today.

9 Nov 2015

MPP announces expansion of mandate to hepatitis C and TB medicines

The Medicines Patent Pool, the world's only voluntary licensing mechanism in public health, announced an expansion of its mandate today to hepatitis C and tuberculosis medicines. The UNITAID Executive Board, meeting November 4-5 in Geneva, approved the MPP's proposals to improve access to both life-saving direct acting antivirals (DAAs) to treat hepatitis C and new and re-purposed medicines for tuberculosis.

6 Nov 2015

GHIT Fund invests $10.7 million to fight malaria, TB, leishmaniasis and dengue

The Global Health Innovative Technology Fund, which in the last two years has invested US$43 million to develop innovative tools for fighting diseases worldwide, today announced it is investing $10.7 million at multiple points in the product development pipeline to seek new interventions for malaria, tuberculosis (TB), leishmaniasis and dengue.

5 Nov 2015

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

A study led by Louise Kuhn, PhD, professor of Epidemiology at Columbia University's Mailman School of Public Health, evaluated whether HIV-infected children in South Africa who had achieved viral suppression with one antiretroviral treatment could transition to efavirenz-based therapy, the recommended drug for children older than 3 years, without risk of viral failure.

4 Nov 2015

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

CureVac, a clinical-stage biopharmaceutical company pioneering the field of mRNA-based technology, today announces that it has raised about $110 million (€100 million) to enable accelerated expansion of its industry-leading messenger RNA (mRNA) development platform and clinical-stage pipeline.

3 Nov 2015

West African man indicted in $12M anti-malaria fraud scheme

The United States Attorney for the Southern District of New York announced the indictment of a citizen of Burkina Faso for his role in a scheme to procure and distribute approximately two million fraudulent and substandard mosquito nets in the West African nation.

31 Oct 2015

Despite reduced HIV/AIDS deaths, disease still persists in South Africa

After peaking in 2007, AIDS mortality in South Africa has decreased with the widespread introduction of effective antiretroviral therapy, according to updated estimates published in AIDS, official journal of the International AIDS Society. AIDS is published by Wolters Kluwer.

30 Oct 2015

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

The fight against tuberculosis is paying off, with this year’s death rate nearly half of what it was in 1990. Nevertheless, 1.5 million people died from TB in 2014. Most of these deaths could have been prevented, according to the World Health Organization’s Global Tuberculosis Report 2015, which was released today in Washington, DC.

29 Oct 2015

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

For about the last 25 years, the cardiology group here have been developing a platform technology for both the diagnosis and treatment of atherosclerosis.

From Beckman Coulter Life Sciences - Particle Counting and Characterization 28 Oct 2015

Major shift needed in global fight against tuberculosis, say researchers

Unless there is a major shift in the way the world fights tuberculosis--from a reliance on biomedical solutions to an approach that combines biomedical interventions with social actions--the epidemic and drug resistance will worsen, say researchers at Harvard T.H. Chan School of Public Health.

26 Oct 2015

New drug delivery method could be used to target cancer, tuberculosis

Scientists have designed a novel method for improving the delivery of therapeutic molecules into diseased cells such as those found in cancer and tuberculosis.

23 Oct 2015

LSTM CL3 lab refurbished by Medical Air Technology

Medical Air Technology (MAT) recently completed a project at the prestigious Liverpool School of Tropical Medicine (LSTM), increasing laboratory capacity to accommodate a new machine for counting and profiling cells. Founded in 1898, LSTM is the oldest School in Tropical Medicine in the world, and recognised globally for its groundbreaking research into infectious, debilitating and disabling diseases.

20 Oct 2015

New report finds tremendous opportunities for TB diagnostics in Brazil, China, India and South Africa

Brazil, China, India and South Africa, which together account for nearly half of all new tuberculosis (TB) cases, offer “tremendous opportunities” for new diagnostics due to their commitment to fight the disease at a time when investments in new technologies are on the increase, according to a new report from FIND, McGill International TB Centre, and UNITAID.

20 Oct 2015

UNITAID report examines new technologies, key market challenges to improved access to better TB diagnostics

More than 50 companies are actively developing new products to diagnose tuberculosis (TB), a disease that killed 1.5 million people in 2013, but many countries still rely on older sputum-based methods, according to a report published by UNITAID.

20 Oct 2015

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Takeda Pharmaceuticals, U.S.A., Inc., today announced that data highlighting the efficacy and safety of vedolizumab for the treatment of adults with moderately to severely active ulcerative colitis (UC) and Crohn's disease (CD), will be presented during the 2015 American College of Gastroenterology Annual Scientific Meeting in Honolulu, Hawaii, held on October 16-21.

20 Oct 2015

Infections experienced in childhood may lead to premature ACS or heart attacks

"Cardiovascular disease (CVD) is the number one killer worldwide, including in Indonesia where it accounts for 31.9% of all deaths," said Dr Qanitha. "CVD risk factors are rising rapidly in South-East Asia, particularly in young people. Most Indonesian CVD patients are under 56 years old and still economically productive. This very young CVD onset raises the question of whether local circumstances may play a role."

19 Oct 2015

Tuberculosis News and Research

Latest Tuberculosis News and Research

TSRI scientists discover first-in-class compounds that target persistent tuberculosis

Study shows how parasitic worm infection increases susceptibility to TB

Analyzing potential TB vaccine

ACR releases 2015 Guideline for Treatment of Rheumatoid Arthritis

New funding for Centenary's life saving research

MPP announces expansion of mandate to hepatitis C and TB medicines

GHIT Fund invests $10.7 million to fight malaria, TB, leishmaniasis and dengue

Study evaluates effectiveness of antiretroviral treatment in HIV-infected children

CureVac raises €100M to enable rapid expansion of mRNA development platform, clinical-stage pipeline

West African man indicted in $12M anti-malaria fraud scheme

Despite reduced HIV/AIDS deaths, disease still persists in South Africa

WHO report reveals significant reduction in TB deaths, but detection, treatment gaps still exist

Liposomal sizing and the Coulter principle: an interview with Professor Melvin E. Klegerman

Major shift needed in global fight against tuberculosis, say researchers

New drug delivery method could be used to target cancer, tuberculosis

LSTM CL3 lab refurbished by Medical Air Technology

New report finds tremendous opportunities for TB diagnostics in Brazil, China, India and South Africa

UNITAID report examines new technologies, key market challenges to improved access to better TB diagnostics

Takeda highlights safety, efficacy of vedolizumab for UC and CD at ACG Annual Scientific Meeting

Infections experienced in childhood may lead to premature ACS or heart attacks

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Tuberculosis News and Research

Latest Tuberculosis News and Research

Clue's CEO Rhiannon White on the Future of Femtech and PCOS

Freezing Point Osmometry in Life Science Applications

Precision in every drop: Inside Hamilton’s syringe technology

Newsletters you may be interested in